Financhill
Back

EPAM Systems Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
36

EPAM
EPAM Systems

Last Price:
$159.33
Seasonality Move:
7.33%
Buy
57

SRPT
Sarepta Therapeutics

Last Price:
$20.30
Seasonality Move:
8.12%
Sell
36
EPAM Systems (EPAM) is a Sell

Is EPAM Systems a Buy, Sell or Hold?

  • The current EPAM Systems [EPAM] share price is $160.80. The Score for EPAM is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • EPAM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $20.40. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EPAM Stock Price Chart

What is EPAM Systems's stock price today?

  • The EPAM Systems share price today is $160.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EPAM is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $20.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

EPAM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 40.75 Buy
Relative Strength Index (14 RSI): 48.39 Sell
Chaikin Money Flow: 717373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (155 - 170.24) Sell
Bollinger Bands (100): (155.71 - 179.05) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.95 Buy
Relative Strength Index (14 RSI): 57.41 Buy
Chaikin Money Flow: 8584996 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.15 - 19.17) Buy
Bollinger Bands (100): (17.93 - 55.55) Sell

EPAM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 154.4 Buy
20-day SMA: 161 Sell
50-day SMA: 168.88 Sell
200-day SMA: 198.18 Sell
8-day EMA: 148.16 Buy
20-day EMA: 108.96 Buy
50-day EMA: 59.52 Buy
200-day EMA: 17.67 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.93 Buy
20-day SMA: 16.17 Buy
50-day SMA: 21.34 Sell
200-day SMA: 76.43 Sell
8-day EMA: 17.44 Buy
20-day EMA: 12.42 Buy
50-day EMA: 6.68 Buy
200-day EMA: 1.97 Buy

EPAM Systems Earnings Growth & EPAM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.77 per share, an increase next quarter of $0.25 per share, an increase this year of $0.18 per share, and an increase next year of $1.11 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.52 per share, an increase next quarter of $1.45 per share, a decrease this year of $5.64 per share, and an increase next year of $5.00 per share.

EPAM Systems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):